nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomitapide—ABCB1—Vinblastine—head and neck cancer	0.164	0.343	CbGbCtD
Lomitapide—ABCB1—Docetaxel—head and neck cancer	0.135	0.282	CbGbCtD
Lomitapide—CYP3A4—Vinblastine—head and neck cancer	0.0981	0.205	CbGbCtD
Lomitapide—CYP3A4—Docetaxel—head and neck cancer	0.0808	0.169	CbGbCtD
Lomitapide—Papule—Hydroxyurea—head and neck cancer	0.0441	0.0873	CcSEcCtD
Lomitapide—Epigastric discomfort—Hydroxyurea—head and neck cancer	0.0183	0.0362	CcSEcCtD
Lomitapide—Antrafenine—PTGS2—head and neck cancer	0.0173	1	CrCbGaD
Lomitapide—Reaction gastrointestinal—Docetaxel—head and neck cancer	0.015	0.0297	CcSEcCtD
Lomitapide—Blister—Hydroxyurea—head and neck cancer	0.0134	0.0264	CcSEcCtD
Lomitapide—Hepatotoxicity—Hydroxyurea—head and neck cancer	0.0125	0.0247	CcSEcCtD
Lomitapide—Hepatic enzyme increased—Hydroxyurea—head and neck cancer	0.0102	0.0201	CcSEcCtD
Lomitapide—Blister—Fluorouracil—head and neck cancer	0.00961	0.019	CcSEcCtD
Lomitapide—Pharyngolaryngeal pain—Docetaxel—head and neck cancer	0.00741	0.0147	CcSEcCtD
Lomitapide—Laryngeal pain—Docetaxel—head and neck cancer	0.00733	0.0145	CcSEcCtD
Lomitapide—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.00731	0.0145	CcSEcCtD
Lomitapide—Rash erythematous—Docetaxel—head and neck cancer	0.00653	0.0129	CcSEcCtD
Lomitapide—Hepatotoxicity—Docetaxel—head and neck cancer	0.00647	0.0128	CcSEcCtD
Lomitapide—Angina pectoris—Vinblastine—head and neck cancer	0.00645	0.0128	CcSEcCtD
Lomitapide—Drug interaction—Docetaxel—head and neck cancer	0.00539	0.0107	CcSEcCtD
Lomitapide—Infestation NOS—Hydroxyurea—head and neck cancer	0.00538	0.0107	CcSEcCtD
Lomitapide—Infestation—Hydroxyurea—head and neck cancer	0.00538	0.0107	CcSEcCtD
Lomitapide—Blood bilirubin increased—Docetaxel—head and neck cancer	0.00529	0.0105	CcSEcCtD
Lomitapide—Dermatitis bullous—Fluorouracil—head and neck cancer	0.00526	0.0104	CcSEcCtD
Lomitapide—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00509	0.0101	CcSEcCtD
Lomitapide—Dry skin—Fluorouracil—head and neck cancer	0.00461	0.00913	CcSEcCtD
Lomitapide—Nasopharyngitis—Fluorouracil—head and neck cancer	0.0045	0.0089	CcSEcCtD
Lomitapide—Chills—Hydroxyurea—head and neck cancer	0.00434	0.00859	CcSEcCtD
Lomitapide—Ill-defined disorder—Vinblastine—head and neck cancer	0.00428	0.00847	CcSEcCtD
Lomitapide—Anaemia—Vinblastine—head and neck cancer	0.00426	0.00844	CcSEcCtD
Lomitapide—Angina pectoris—Fluorouracil—head and neck cancer	0.00423	0.00838	CcSEcCtD
Lomitapide—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00417	0.00826	CcSEcCtD
Lomitapide—Malaise—Vinblastine—head and neck cancer	0.00416	0.00824	CcSEcCtD
Lomitapide—Vertigo—Vinblastine—head and neck cancer	0.00414	0.00821	CcSEcCtD
Lomitapide—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.0039	0.00773	CcSEcCtD
Lomitapide—Anaemia—Hydroxyurea—head and neck cancer	0.00389	0.0077	CcSEcCtD
Lomitapide—Discomfort—Vinblastine—head and neck cancer	0.00388	0.00768	CcSEcCtD
Lomitapide—Infestation NOS—Fluorouracil—head and neck cancer	0.00387	0.00767	CcSEcCtD
Lomitapide—Infestation—Fluorouracil—head and neck cancer	0.00387	0.00767	CcSEcCtD
Lomitapide—Dermatitis bullous—Docetaxel—head and neck cancer	0.0038	0.00752	CcSEcCtD
Lomitapide—Malaise—Hydroxyurea—head and neck cancer	0.00379	0.00751	CcSEcCtD
Lomitapide—Sinusitis—Fluorouracil—head and neck cancer	0.00364	0.0072	CcSEcCtD
Lomitapide—Pain in extremity—Docetaxel—head and neck cancer	0.00363	0.00719	CcSEcCtD
Lomitapide—Migraine—Docetaxel—head and neck cancer	0.00357	0.00707	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00356	0.00704	CcSEcCtD
Lomitapide—Discomfort—Hydroxyurea—head and neck cancer	0.00354	0.00701	CcSEcCtD
Lomitapide—Infection—Hydroxyurea—head and neck cancer	0.00341	0.00675	CcSEcCtD
Lomitapide—Paraesthesia—Vinblastine—head and neck cancer	0.00338	0.00669	CcSEcCtD
Lomitapide—Dehydration—Docetaxel—head and neck cancer	0.00337	0.00668	CcSEcCtD
Lomitapide—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00337	0.00667	CcSEcCtD
Lomitapide—Liver function test abnormal—Docetaxel—head and neck cancer	0.00335	0.00663	CcSEcCtD
Lomitapide—Skin disorder—Hydroxyurea—head and neck cancer	0.00333	0.0066	CcSEcCtD
Lomitapide—Dry skin—Docetaxel—head and neck cancer	0.00333	0.00659	CcSEcCtD
Lomitapide—Abdominal pain upper—Docetaxel—head and neck cancer	0.00331	0.00656	CcSEcCtD
Lomitapide—Decreased appetite—Vinblastine—head and neck cancer	0.00327	0.00648	CcSEcCtD
Lomitapide—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00327	0.00647	CcSEcCtD
Lomitapide—Nasopharyngitis—Docetaxel—head and neck cancer	0.00325	0.00643	CcSEcCtD
Lomitapide—Constipation—Vinblastine—head and neck cancer	0.00322	0.00637	CcSEcCtD
Lomitapide—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.0032	0.00634	CcSEcCtD
Lomitapide—Feeling abnormal—Vinblastine—head and neck cancer	0.0031	0.00614	CcSEcCtD
Lomitapide—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00308	0.0061	CcSEcCtD
Lomitapide—Angina pectoris—Docetaxel—head and neck cancer	0.00306	0.00605	CcSEcCtD
Lomitapide—Somnolence—Hydroxyurea—head and neck cancer	0.00305	0.00604	CcSEcCtD
Lomitapide—Dyspepsia—Hydroxyurea—head and neck cancer	0.00302	0.00598	CcSEcCtD
Lomitapide—Decreased appetite—Hydroxyurea—head and neck cancer	0.00298	0.00591	CcSEcCtD
Lomitapide—Abdominal pain—Vinblastine—head and neck cancer	0.00298	0.00589	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00296	0.00587	CcSEcCtD
Lomitapide—Fatigue—Hydroxyurea—head and neck cancer	0.00296	0.00586	CcSEcCtD
Lomitapide—Constipation—Hydroxyurea—head and neck cancer	0.00294	0.00581	CcSEcCtD
Lomitapide—Weight decreased—Docetaxel—head and neck cancer	0.00284	0.00562	CcSEcCtD
Lomitapide—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00283	0.0056	CcSEcCtD
Lomitapide—Anaemia—Fluorouracil—head and neck cancer	0.0028	0.00554	CcSEcCtD
Lomitapide—Infestation NOS—Docetaxel—head and neck cancer	0.0028	0.00554	CcSEcCtD
Lomitapide—Infestation—Docetaxel—head and neck cancer	0.0028	0.00554	CcSEcCtD
Lomitapide—Body temperature increased—Hydroxyurea—head and neck cancer	0.00271	0.00537	CcSEcCtD
Lomitapide—Asthenia—Vinblastine—head and neck cancer	0.0027	0.00535	CcSEcCtD
Lomitapide—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00264	0.00524	CcSEcCtD
Lomitapide—Chest pain—Fluorouracil—head and neck cancer	0.00258	0.0051	CcSEcCtD
Lomitapide—Myalgia—Fluorouracil—head and neck cancer	0.00258	0.0051	CcSEcCtD
Lomitapide—Diarrhoea—Vinblastine—head and neck cancer	0.00258	0.0051	CcSEcCtD
Lomitapide—Discomfort—Fluorouracil—head and neck cancer	0.00255	0.00504	CcSEcCtD
Lomitapide—Dizziness—Vinblastine—head and neck cancer	0.00249	0.00493	CcSEcCtD
Lomitapide—Urinary tract disorder—Docetaxel—head and neck cancer	0.00248	0.00491	CcSEcCtD
Lomitapide—Connective tissue disorder—Docetaxel—head and neck cancer	0.00247	0.00488	CcSEcCtD
Lomitapide—Asthenia—Hydroxyurea—head and neck cancer	0.00246	0.00488	CcSEcCtD
Lomitapide—Urethral disorder—Docetaxel—head and neck cancer	0.00246	0.00487	CcSEcCtD
Lomitapide—Infection—Fluorouracil—head and neck cancer	0.00246	0.00486	CcSEcCtD
Lomitapide—Nervous system disorder—Fluorouracil—head and neck cancer	0.00242	0.0048	CcSEcCtD
Lomitapide—Vomiting—Vinblastine—head and neck cancer	0.00239	0.00474	CcSEcCtD
Lomitapide—Headache—Vinblastine—head and neck cancer	0.00236	0.00467	CcSEcCtD
Lomitapide—Diarrhoea—Hydroxyurea—head and neck cancer	0.00235	0.00465	CcSEcCtD
Lomitapide—Eye disorder—Docetaxel—head and neck cancer	0.00235	0.00465	CcSEcCtD
Lomitapide—Cardiac disorder—Docetaxel—head and neck cancer	0.00233	0.00461	CcSEcCtD
Lomitapide—Dizziness—Hydroxyurea—head and neck cancer	0.00227	0.0045	CcSEcCtD
Lomitapide—Mediastinal disorder—Docetaxel—head and neck cancer	0.00226	0.00448	CcSEcCtD
Lomitapide—Chills—Docetaxel—head and neck cancer	0.00225	0.00446	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00225	0.00446	CcSEcCtD
Lomitapide—Nausea—Vinblastine—head and neck cancer	0.00224	0.00443	CcSEcCtD
Lomitapide—Paraesthesia—Fluorouracil—head and neck cancer	0.00222	0.00439	CcSEcCtD
Lomitapide—Somnolence—Fluorouracil—head and neck cancer	0.0022	0.00435	CcSEcCtD
Lomitapide—Malnutrition—Docetaxel—head and neck cancer	0.00219	0.00433	CcSEcCtD
Lomitapide—Vomiting—Hydroxyurea—head and neck cancer	0.00218	0.00432	CcSEcCtD
Lomitapide—Dyspepsia—Fluorouracil—head and neck cancer	0.00218	0.00431	CcSEcCtD
Lomitapide—Headache—Hydroxyurea—head and neck cancer	0.00215	0.00426	CcSEcCtD
Lomitapide—Decreased appetite—Fluorouracil—head and neck cancer	0.00215	0.00425	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00213	0.00422	CcSEcCtD
Lomitapide—Back pain—Docetaxel—head and neck cancer	0.00211	0.00419	CcSEcCtD
Lomitapide—Muscle spasms—Docetaxel—head and neck cancer	0.0021	0.00416	CcSEcCtD
Lomitapide—Nausea—Hydroxyurea—head and neck cancer	0.00204	0.00404	CcSEcCtD
Lomitapide—Feeling abnormal—Fluorouracil—head and neck cancer	0.00204	0.00403	CcSEcCtD
Lomitapide—Anaemia—Docetaxel—head and neck cancer	0.00202	0.004	CcSEcCtD
Lomitapide—Body temperature increased—Fluorouracil—head and neck cancer	0.00195	0.00387	CcSEcCtD
Lomitapide—Palpitations—Docetaxel—head and neck cancer	0.00193	0.00382	CcSEcCtD
Lomitapide—Chest pain—Docetaxel—head and neck cancer	0.00186	0.00368	CcSEcCtD
Lomitapide—Myalgia—Docetaxel—head and neck cancer	0.00186	0.00368	CcSEcCtD
Lomitapide—Arthralgia—Docetaxel—head and neck cancer	0.00186	0.00368	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00185	0.00366	CcSEcCtD
Lomitapide—Dry mouth—Docetaxel—head and neck cancer	0.00182	0.0036	CcSEcCtD
Lomitapide—Infection—Docetaxel—head and neck cancer	0.00177	0.00351	CcSEcCtD
Lomitapide—Nervous system disorder—Docetaxel—head and neck cancer	0.00175	0.00346	CcSEcCtD
Lomitapide—Skin disorder—Docetaxel—head and neck cancer	0.00173	0.00343	CcSEcCtD
Lomitapide—Diarrhoea—Fluorouracil—head and neck cancer	0.00169	0.00335	CcSEcCtD
Lomitapide—Dizziness—Fluorouracil—head and neck cancer	0.00163	0.00324	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00163	0.00322	CcSEcCtD
Lomitapide—Paraesthesia—Docetaxel—head and neck cancer	0.0016	0.00317	CcSEcCtD
Lomitapide—Somnolence—Docetaxel—head and neck cancer	0.00159	0.00314	CcSEcCtD
Lomitapide—Vomiting—Fluorouracil—head and neck cancer	0.00157	0.00311	CcSEcCtD
Lomitapide—Dyspepsia—Docetaxel—head and neck cancer	0.00157	0.00311	CcSEcCtD
Lomitapide—Decreased appetite—Docetaxel—head and neck cancer	0.00155	0.00307	CcSEcCtD
Lomitapide—Headache—Fluorouracil—head and neck cancer	0.00155	0.00307	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00154	0.00305	CcSEcCtD
Lomitapide—Fatigue—Docetaxel—head and neck cancer	0.00154	0.00304	CcSEcCtD
Lomitapide—Constipation—Docetaxel—head and neck cancer	0.00153	0.00302	CcSEcCtD
Lomitapide—Feeling abnormal—Docetaxel—head and neck cancer	0.00147	0.00291	CcSEcCtD
Lomitapide—Nausea—Fluorouracil—head and neck cancer	0.00147	0.00291	CcSEcCtD
Lomitapide—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00146	0.00289	CcSEcCtD
Lomitapide—Body temperature increased—Docetaxel—head and neck cancer	0.00141	0.00279	CcSEcCtD
Lomitapide—Abdominal pain—Docetaxel—head and neck cancer	0.00141	0.00279	CcSEcCtD
Lomitapide—Asthenia—Docetaxel—head and neck cancer	0.00128	0.00253	CcSEcCtD
Lomitapide—Diarrhoea—Docetaxel—head and neck cancer	0.00122	0.00242	CcSEcCtD
Lomitapide—Dizziness—Docetaxel—head and neck cancer	0.00118	0.00234	CcSEcCtD
Lomitapide—Vomiting—Docetaxel—head and neck cancer	0.00113	0.00225	CcSEcCtD
Lomitapide—Headache—Docetaxel—head and neck cancer	0.00112	0.00221	CcSEcCtD
Lomitapide—Nausea—Docetaxel—head and neck cancer	0.00106	0.0021	CcSEcCtD
